Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Campbell, I. W
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Editorial

NICE 2008 guidelines on continuous subcutaneous insulin infusion therapy and their impact on management of specific patient populations

Ian W Campbell

Ian Campbell Victoria Hospital, Hayfield Road, Kirkcaldy, Fife, Scotland, KY2 5AH, UK, Jackie.Wallace{at}faht.scot.nhs.uk

References

  • National Institute for Health and Clinical Excellence. NICE technology appraisal guidance 151. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57). London: National Institute for Health and Clinical Excellence, July 2008. http://www.nice.org.uk/TA151 (Accessed 23 July 2008).
  • Kerr D. Continuous subcutaneous insulin infusion therapy and children with type 1 diabetes mellitus: the 2008 updated NICE guidelines. Br J Diabetes Vasc Dis 2008; 8:(Suppl 1): S2-5
  • Campbell F. The pros and cons of continuous subcutaneous insulin infusion (CSII) therapy in the paediatric population and practical considerations when choosing and initiating CSII in children. Br J Diabetes Vasc Dis 2008; 8:(Suppl 1): S6-10
  • Hammond P. Use of continuous subcutaneous insulin infusion in special populations and circumstances in patients with type 1 diabetes. Br J Diabetes Vasc Dis 2008; 8:(Suppl 1): S11-14

The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 1 suppl, S1 (2008)
DOI: 10.1177/1474651408097725
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Campbell, I. W
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?